ArticleAmerican journal of cancer research2025
Patho-Net: enhancing breast cancer classification using deep learning and explainable artificial intelligence.
Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interpretable CRAM‑Enhanced Lightweight Dual‑Branch CNN for Real‑Time Breast Cancer Histopathology in Internet‑of‑Medical‑Things Environments.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a disorder affecting women globally, and hence an early and precise classification is the best possible treatment to increase the survival rate. However, the breast cancer classification faced difficulties in scalability, fixed-size input images, and overfitting on limited datasets. To tackle these issues, this work proposes a Patho-Net model for breast cancer classification that overcomes the problems of scalability in color normalization, integrates the Gated Recurrent Unit (GRU) network with the U-Net architecture to process images without the need for resizing and computational efficiency, and addresses the overfitting problems. The proposed model collects and normalizes histopathology images using automated reference image selection with the Reinhard method for color standardization. Also, the Enhanced Adaptive Non-Local Means (EANLM) filtering is utilized for noise removal to preserve image features. These preprocessed images undergo semantic segmentation to isolate specific parts of an image, followed by feature extraction using an Improved Gray Level Co-occurrence Matrix (I-GLCM) to reveal fine patterns and textures in images. These features serve as input into the classification U-Net model integrated with GRU networks to improve the model performance. Finally, the classification result is expanded, and XAI is used for clear visual explanations of the model's predictions. The proposed Patho-Net model, which uses the 100X BreakHis dataset, achieves an accuracy of 98.90% in the classification of breast cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.